<DOC>
	<DOC>NCT02239354</DOC>
	<brief_summary>The purpose of this trial is to test if VC-01™ combination product can be implanted subcutaneously in subjects with Type 1 Diabetes and maintained safely for two years. It will also test if VC-01 is an effective treatment for subjects with Type 1 Diabetes.</brief_summary>
	<brief_title>A Safety, Tolerability, and Efficacy Study of VC-01™ Combination Product in Subjects With Type I Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<criteria>Men and women (nonpregnant and nonchildbearing potential) Diagnosis of type 1 diabetes mellitus for at least 3 years Stable diabetic treatment Willingness to use a continuous glucose meter Acceptable candidate for implantation Advanced complications associated with diabetes Immunosuppressive therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>